• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JRNY II CR FEM COCR NP RT SZ 7; PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JRNY II CR FEM COCR NP RT SZ 7; PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER Back to Search Results
Catalog Number 74021257
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Loss of Range of Motion (2032); Scar Tissue (2060); Fibrosis (3167); Swelling/ Edema (4577)
Event Date 07/22/2022
Event Type  Injury  
Event Description
It was reported that, after a tka was performed on (b)(6) 2022, the patient experienced issues with scar tissue growth, pain, and swelling which seems to be limiting his range of motion.In (b)(6) 2022 a knee manipulation was performed which actually reduced the knee range of motion even more.Over the last 9 months with orthoepic massage and physical therapy patient can extend his leg to 10 deg and flex it to 110 deg, with popping.Current health status patient is unknown.
 
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Manufacturer Narrative
H3, h6.The device was not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, as of the date of this medical investigation, the supporting clinical documentation has not been provided; therefore, definitive clinical factors could not be concluded to have contributed to the reported event.However, scar tissue formation is a known post-surgical occurrence and is not indicative of a component malperformance.Patient impact beyond the reported post-tka symptoms, subsequent manipulation, and ongoing range of motion limitations with popping cannot be determined.No further medical assessment can be rendered at this time.Device specific identifiers were not provided.Therefore, an evaluation of the manufacturing records, complaint history review, instructions for use, risk management file and prior actions review could not be performed.At this time, we have no reason to suspect that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include traumatic injury, patient condition or postoperative care.Based on this investigation, the need for corrective action is not indicated.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Manufacturer Narrative
H10.B7 and h6 (health effect - clinical code and health effect - impact code).
 
Event Description
It was reported that, after a visionaire assisted right tkr was performed on (b)(6) 2022, the patient experienced issues with scar tissue growth, pain, and swelling which seems to be limiting his range of motion.On (b)(6) 2022, a knee manipulation was performed which reduced the knee range of motion even more.Over the last 9 months with orthoepic massage and physical therapy patient can extend his leg to 10 deg and flex it to 110 deg, with popping.The patient kept suffering from persistent stiffness.On (b)(6) 2023, the main symptoms were loss of extension and abnormal gait.On (b)(6) 2023, the patient underwent a right knee arthroscopy with lysis of adhesions and a manipulation under anesthesia.The patient is making progress, but it¿s still very slow and limited.On 25-jul-2023 the patient indicated that over the last three (3) months there have not been any more improvements.
 
Manufacturer Narrative
H10.Additional information in a2, a3, a4, b7, d1, d2, d4, d10, g4 and h9.H11.Corrected information in b3 and b5.
 
Event Description
It was reported that, after a visionaire assisted right tkr was performed on (b)(6) 2022, the patient experienced issues with scar tissue growth, pain, and swelling which seems to be limiting his range of motion.On (b)(6) 2022, a knee manipulation was performed which reduced the knee range of motion even more.Over the last 9 months with orthoepic massage and physical therapy patient can extend his leg to 10 deg and flex it to 110 deg, with popping.The patient kept suffering from persistent stiffness.On (b)(6) 2023, the main symptoms were loss of extension and abnormal gait.On (b)(6) 2023, the patient underwent a right knee arthroscopy with lysis of adhesions and a manipulation under anesthesia.The patient is making progress, but it¿s still very slow and limited.On (b)(6) 2023 the patient indicated that over the last three (3) months there have not been any more improvements.On (b)(6) 2023 a iovera treatment was performed to help reduce the pain; however, the swelling, stiffness and deep pain continues.
 
Manufacturer Narrative
B5: describe event or problem.Section h3, h6: given the nature of the alleged incident the devices could not be returned for evaluation.The clinical/medical investigation concluded that, based on the documentation provided, the reported extensive arthrofibrosis contributed to the reported patient symptoms and is a known post-surgical occurrence not indicative of a component malperformance; however, it is unknown if the patient has a sensitivity or comorbidity that would possibly contribute to the severity and/or recurrence of the symptoms.Additionally, the possible baseplate medial overhang and noted mild valgus alignment cannot be ruled out as potential contributing factors.The patient impact included the reported symptoms, additional arthroscopy, two manipulation under anesthesia, cryoanalgesia therapy, physical therapy with massage, and reported persistent deep pain, swelling and range of motion limitations.Further patient impact could not be determined.No further medical assessment can be rendered at this time.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.For journey ii xr articular insert xlpe medial size 5-6 right 9mm a review of complaint history based on the historical data revealed a similar event for the listed batch, this failure mode will be monitored for future complaints for any necessary corrective actions.For the rest of the devices a review of complaint history for the part numbers over the past 12 months and for the batch numbers based on historical data of the device did not reveal similar events for the listed device.A review of the instructions for use documents for knee systems revealed in the possible adverse effects section that decreased range of motion and unusual stress concentrations can result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no reason to suspect that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include traumatic injury, patient condition, patient medical history and/or postoperative care.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.D4: catalog#.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JRNY II CR FEM COCR NP RT SZ 7
Type of Device
PROSTHESIS, KNEE, FEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16620738
MDR Text Key312286137
Report Number1020279-2023-00670
Device Sequence Number1
Product Code HRY
UDI-Device Identifier00885556615195
UDI-Public00885556615195
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121393
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number74021257
Device Lot NumberB1710600
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/14/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
71926225 / 21KM14994.; 74023751 / 16FM16776.; 74023851 / 17MM06603.; 74023851 / 18CM21360.
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexMale
Patient Weight89 KG
-
-